UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="MFteva-50mcg-Suspension-SE-IS-MPD-BBDL"/>
<type value="collection"/>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
<resource>
<MedicinalProductDefinition>
<id value="MFteva-50mcg-Suspension-SE-IS-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_MFteva-50mcg-Suspension-SE-IS-MPD"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition MFteva-50mcg-Suspension-SE-IS-MPD</b></p><a name="MFteva-50mcg-Suspension-SE-IS-MPD"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-MPD"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001594-00048308, <code>http://ema.europa.eu/fhir/eurdId</code>/2085</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073809}">Nasal spray, suspension</span></p><p><b>indication</b>: </p><div><p>Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 200000002239}">Medicinal product subject to medical prescription exempt for some pack sizes</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000116677 100000093533}">R01AD09</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Mometason Teva 50 mikrogram/dos Nässpray, suspension</p><blockquote><p><b>part</b></p><p><b>part</b>: Mometason Teva</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 50 mikrogram/dos</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Nässpray, suspension</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-100001594-00048308"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="2085"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073809"/>
<display value="Nasal spray, suspension"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre."/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="200000002239"/>
<display
value="Medicinal product subject to medical prescription exempt for some pack sizes"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000116677"/>
<code value="100000093533"/>
<display value="R01AD09"/>
</coding>
</classification>
<name>
<productName
value="Mometason Teva 50 mikrogram/dos Nässpray, suspension"/>
<part>
<part value="Mometason Teva"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</part>
<part>
<part value="50 mikrogram/dos"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="Nässpray, suspension"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/MFteva-50mcg-Suspension-SE-IS-RA"/>
<resource>
<RegulatedAuthorization>
<id value="MFteva-50mcg-Suspension-SE-IS-RA"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_MFteva-50mcg-Suspension-SE-IS-RA"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MFteva-50mcg-Suspension-SE-IS-RA</b></p><a name="MFteva-50mcg-Suspension-SE-IS-RA"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-RA"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/48308</p><p><b>subject</b>: <a href="MedicinalProductDefinition-MFteva-50mcg-Suspension-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00048308,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 2013-10-31</p><p><b>holder</b>: <a href="Organization-LOC-100001602.html">Organization Teva Sweden AB</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>2013-10-31</td></tr></table></div>
</text>
<identifier>
<system
value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
<value value="48308"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</region>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
<code value="100000072099"/>
<display value="Valid"/>
</coding>
</status>
<statusDate value="2013-10-31"/>
<holder>🔗
<reference value="Organization/LOC-100001602"/>
</holder>
<case>
<type>
<coding>
<system
value="https://ema.europa.eu/fhir/authorisationDateType"/>
<code value="dateOfFirstAuthorisation"/>
<display value="First Authorisation"/>
</coding>
</type>
<dateDateTime value="2013-10-31"/>
</case>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/MFteva-50mcg-Suspension-SE-IS-PPD01"/>
<resource>
<PackagedProductDefinition>
<id value="MFteva-50mcg-Suspension-SE-IS-PPD01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_MFteva-50mcg-Suspension-SE-IS-PPD01"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition MFteva-50mcg-Suspension-SE-IS-PPD01</b></p><a name="MFteva-50mcg-Suspension-SE-IS-PPD01"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-PPD01"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-PPD01-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-MFteva-50mcg-Suspension-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00048308,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09</a></p><p><b>containedItemQuantity</b>: 1 Bottle<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002111 = '200000002111')</span></p><p><b>description</b>: </p><div><p>Plastflaska med dospump, 140 doser</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="1"/>
<unit value="Bottle"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002111"/>
</containedItemQuantity>
<description value="Plastflaska med dospump, 140 doser"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000125779"/>
<display value="Multidose container with pump"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003214"/>
<display value="PolyEthylene"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003219"/>
<display value="PolyPropylene"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/MFteva-50mcg-Suspension-SE-IS-MID"/>
</reference>
</item>
<amount>
<value value="50"/>
<unit value="microgram(s)/dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110920"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/MFteva-50mcg-Suspension-SE-IS-PPD02"/>
<resource>
<PackagedProductDefinition>
<id value="MFteva-50mcg-Suspension-SE-IS-PPD02"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_MFteva-50mcg-Suspension-SE-IS-PPD02"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition MFteva-50mcg-Suspension-SE-IS-PPD02</b></p><a name="MFteva-50mcg-Suspension-SE-IS-PPD02"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-PPD02"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-PPD02-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-MFteva-50mcg-Suspension-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00048308,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09</a></p><p><b>containedItemQuantity</b>: 3 Bottle<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002111 = '200000002111')</span></p><p><b>description</b>: </p><div><p>Flaska med dospump, 3 x 140 doser</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="3"/>
<unit value="Bottle"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002111"/>
</containedItemQuantity>
<description value="Flaska med dospump, 3 x 140 doser"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000125779"/>
<display value="Multidose container with pump"/>
</coding>
</type>
<quantity value="3"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003214"/>
<display value="PolyEthylene"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003219"/>
<display value="PolyPropylene"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/MFteva-50mcg-Suspension-SE-IS-MID"/>
</reference>
</item>
<amount>
<value value="50"/>
<unit value="microgram(s)/dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110920"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/MFteva-50mcg-Suspension-SE-IS-MID"/>
<resource>
<ManufacturedItemDefinition>
<id value="MFteva-50mcg-Suspension-SE-IS-MID"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_MFteva-50mcg-Suspension-SE-IS-MID"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition MFteva-50mcg-Suspension-SE-IS-MID</b></p><a name="MFteva-50mcg-Suspension-SE-IS-MID"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-MID"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-MID-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073809}">Nasal spray, suspension</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002111}">Bottle</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073809"/>
<display value="Nasal spray, suspension"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002111"/>
<display value="Bottle"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/MFteva-50mcg-Suspension-SE-IS-ING"/>
<resource>
<Ingredient>
<id value="MFteva-50mcg-Suspension-SE-IS-ING"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_MFteva-50mcg-Suspension-SE-IS-ING"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient MFteva-50mcg-Suspension-SE-IS-ING</b></p><a name="MFteva-50mcg-Suspension-SE-IS-ING"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-ING"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-ING-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-MFteva-50mcg-Suspension-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00048308,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09</a></li><li><a href="ManufacturedItemDefinition-MFteva-50mcg-Suspension-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Nasal spray, suspension; unitOfPresentation = Bottle</a></li><li><a href="AdministrableProductDefinition-MFteva-50mcg-Suspension-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Suspension for spray</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000137366}">Mometasone furoate monohydrate</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>concentration</b>: 0.052 milligram(s)/dose<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110921 = '100000110921')</span>/1 dose<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code200000025238 = '200000025238')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091860}">Mometasone furoate</span></td></tr></table><p><b>strength</b>: 50 microgram(s)/dose<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110920 = '100000110920')</span>/1 dose<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code200000025238 = '200000025238')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/MFteva-50mcg-Suspension-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/MFteva-50mcg-Suspension-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000137366"/>
<display value="Mometasone furoate monohydrate"/>
</coding>
</concept>
</code>
<strength>
<concentrationRatio>
<numerator>
<value value="0.052"/>
<unit value="milligram(s)/dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110921"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="200000025238"/>
</denominator>
</concentrationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091860"/>
<display value="Mometasone furoate"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="50"/>
<unit value="microgram(s)/dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110920"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="dose"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="200000025238"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/MFteva-50mcg-Suspension-SE-IS-APD"/>
<resource>
<AdministrableProductDefinition>
<id value="MFteva-50mcg-Suspension-SE-IS-APD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_MFteva-50mcg-Suspension-SE-IS-APD"> </a><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition MFteva-50mcg-Suspension-SE-IS-APD</b></p><a name="MFteva-50mcg-Suspension-SE-IS-APD"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-APD"> </a><a name="hcMFteva-50mcg-Suspension-SE-IS-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-MFteva-50mcg-Suspension-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00048308,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometasone Teva nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometasone Teva nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000174018}">Suspension for spray</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-MFteva-50mcg-Suspension-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Nasal spray, suspension; unitOfPresentation = Bottle</a></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073615}">Nasal use</span></td></tr></table></div>
</text>
<status value="active"/>
<formOf>🔗
<reference
value="MedicinalProductDefinition/MFteva-50mcg-Suspension-SE-IS-MPD"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000174018"/>
<display value="Suspension for spray"/>
</coding>
</administrableDoseForm>
<producedFrom>🔗
<reference
value="ManufacturedItemDefinition/MFteva-50mcg-Suspension-SE-IS-MID"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
<code value="100000073615"/>
<display value="Nasal use"/>
</coding>
</code>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100001602"/>
<resource>
<Organization>
<id value="LOC-100001602"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_LOC-100001602"> </a><p class="res-header-id"><b>Generated Narrative: Organization LOC-100001602</b></p><a name="LOC-100001602"> </a><a name="hcLOC-100001602"> </a><a name="hcLOC-100001602-en-US"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100001602</p><p><b>name</b>: Teva Sweden AB</p></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/v1/locations"/>
<value value="LOC-100001602"/>
</identifier>
<name value="Teva Sweden AB"/>
</Organization>
</resource>
</entry>
</Bundle>
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
